Sale by Jeremy G Chadwick (Chief Operating Officer)
300 shares · @ $90.00 · $27,000
Kymera Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $78.47
-4.0% in 3d after detection
Post-detection moves
1h
—
1d
+2.1%
3d
-4.0%
7d
-2.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS